| abstract |
The present invention relates to a pharmaceutical composition for preventing or treating diabetes complications comprising a novel chrysin derivative compound as an active ingredient and, more specifically, to a pharmaceutical composition for preventing or treating diabetes complications comprising, as an active ingredient, a novel chrysin derivative compound which has an effect of inhibiting the formation of an advanced glycation end product (AGE) and can, thereby, prevent or treat diabetes complications. |